- Comment
- Open access
- Published:
Letter to the editor: Incidence rate of occult lymph node metastasis in clinical T1 − 2N0M0 small cell lung cancer patients and radiomic prediction based on contrast-enhanced CT imaging: a multicenter study
Respiratory Research volume 25, Article number: 408 (2024)
Recently, we had the honor of reading the article titled " Incidence rate of occult lymph node metastasis in clinical T1 − 2N0M0 small cell lung cancer patients and radiomic prediction based on contrast-enhanced CT imaging: a multicenter study “ [1]. This study retrospectively included 242 eligible patients from 4 centers to determine the incidence of OLM in cT1 − 2N0M0 SCLC patients. For each lesion, two ROIs were defined using total tumor volume ( GTV ) and peritumoral 15 mm volume ( PTV ). Five models were constructed by extracting 1595 radiologic features based on enhanced ct from GTV and PTV, and the performance of the models was evaluated using indicators such as area under the curve ( AUC ), accuracy, sensitivity, specificity, calibration curve and decision curve analysis ( DCA ). At the same time, clinical parameters and rad _ score ( GTV and PTV ) were included to construct nomogram. The combined model combines three radiological features of GTV and PTV, as well as two clinical parameters ( smoking status and body size ), showing strong predictive power. In the external validation cohort, the peak AUC value of the model is 0.772, which is better than the alternative model. The nomogram can significantly improve the diagnostic accuracy of radiologists and add substantial value to the clinical decision-making process of patients with cT1 − 2N0M0 SCLC.
We sincerely appreciate the contributions made by the authors. However, there are issues in this study that require further exploration.The clinical factors included in this study lacked laboratory indicators such as CEA, CA153, CA199, and CA125. CEA can be used as a predictive marker for the risk of recurrence and death measured over time. There is a certain correlation between the degree of CEA elevation and lung cancer, and with the increase of TNM stage, the serum level is also increased [2]. CA153, CA199 and CA125 are related to the diagnosis, identification and prognosis of lung cancer [3, 4]. These indicators can reflect the degree of differentiation and malignancy of lung cancer to a certain extent. And these indicators have a certain correlation with tumor metastasis. At the same time, these laboratory indicators are often checked when the patient is admitted to the hospital, and the acquisition is relatively simple. If these laboratory indicators are included in the nomogram through statistical tests, it is expected to further improve the model performance.
Finally, we express our gratitude once again for the authors’ contributions to this study. We hope our insights prove valuable for their further research, and we look forward to hearing their opinions.
Data availability
No datasets were generated or analysed during the current study.
References
Jiang X, Luo C, Peng X, et al. Incidence rate of occult lymph node metastasis in clinical T(1–2)N(0)M(0) small cell lung cancer patients and radiomic prediction based on contrast-enhanced CT imaging: a multicenter study: original research [J]. Respir Res. 2024;25(1):226.
Grunnet M, Sorensen JB. Carcinoembryonic antigen (CEA) as tumor marker in lung cancer [J]. Lung Cancer. 2012;76(2):138–43.
Wang C F, Peng S J, Liu R Q et al. The Combination of CA125 and NSE Is Useful for Predicting Liver Metastasis of Lung Cancer [J]. Dis Markers, 2020, 2020: 8850873.
Ge Q M, Zou Y T, Shi W Q, et al. Ocular metastasis in Elderly Lung Cancer patients: potential risk factors of CA-125, CA-153 and TPSA [J]. Cancer Manag Res. 2020;12:1801–8.
Acknowledgements
None.
Funding
None.
Author information
Authors and Affiliations
Contributions
Zhe Hu, MD (Contribution: Roles/Writing – original draft); Zhikang Tian, MD (Contribution: Roles/Writing – original draft); Xi Wei, MD (Contribution: Software); Yueqin Chen, MD (Contribution: Writing – review & editing).
Corresponding author
Ethics declarations
Ethics approval and consent to participate
No.
Consent for publication
All authors agree to publish.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Hu, Z., Tian, Z., Wei, X. et al. Letter to the editor: Incidence rate of occult lymph node metastasis in clinical T1 − 2N0M0 small cell lung cancer patients and radiomic prediction based on contrast-enhanced CT imaging: a multicenter study. Respir Res 25, 408 (2024). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12931-024-02940-w
Received:
Accepted:
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12931-024-02940-w